India's Marksans Pharma slumps 10% as quarterly profit drops
** Marksans Pharma MARK.NS slumps 10% to four-month low of 189 rupees; set for sixth consecutive session of losses ** Stock on course for biggest daily pct drop since April 4 ** Co's Q1 consolidated profit falls 34% on higher costs ** Around 3 million shares change hands so far, about 2.3x 30-day avg volume ** YTD, MARK down 36.3% (Reporting by Vivek Kumar M) ((VivekKumar.M@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg